(3R,4S,5S,6R)-6-[[(2S,3R,4R,5R)-3,4-Dihydroxy-5-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Term ID

CHEBI:150063

Synonyms

alpha-D-xylo-pentopyranosyl-(1->4)-alpha-D-xylo-pentopyranosyl-(1->6)-D-gluco-hexopyranose
WURCS=2.0/2,3,2/[a2122h-1x_1-5][a212h-1a_1-5]/1-2-2/a6-b1_b4-c1
Xyl(a1-4)Xyl(a1-6)Glc

Definition

References

GlyGen:G40164WC
GlyTouCan:G40164WC

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (3R,4S,5S,6R)-6-[[(2S,3R,4R,5R)-3,4-Dihydroxy-5-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Phenotype where environments contain (3R,4S,5S,6R)-6-[[(2S,3R,4R,5R)-3,4-Dihydroxy-5-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Phenotype modified by environments containing (3R,4S,5S,6R)-6-[[(2S,3R,4R,5R)-3,4-Dihydroxy-5-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Phenotype affecting (3R,4S,5S,6R)-6-[[(2S,3R,4R,5R)-3,4-Dihydroxy-5-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Human Disease Model